Victory Capital Management
DARE icon

Victory Capital Management’s Dare Bioscience DARE Stock Holding History

Victory Capital Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-952
Closed -$14K – 2716
2022
Q2 		$14K Sell
952
-13
-1% -$196 ﹤0.01% 2634
2022
Q1 		$13K Buy
965
+73
+8% +$1.38K ﹤0.01% 2661
2021
Q4 		$21K Buy
892
+46
+5% +$946 ﹤0.01% 2691
2021
Q3 		$17K Buy
+846
New +$16.7K ﹤0.01% 2737
2020
Q2 		– Sell
-637
Closed -$6K – 2711
2020
Q1 		$6K Buy
+637
New +$8.57K ﹤0.01% 3423
2019
Q4 		– Sell
-215
Closed -$2K – 2803
2019
Q3 		$2K Buy
+215
New +$2.06K ﹤0.01% 3621

Other funds holding DARE

FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management's DARE Position: Q3 2022 in Review

Victory Capital Management sold out of Dare Bioscience (DARE) in Q3 2022, closing a stake of 952 shares — an estimated $14K sold.

Victory Capital Management first reported a position in DARE in Q3 2019 and held it in 6 quarters. The position peaked at $21K in Q4 2021. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2022.

  • Victory Capital Management reported no remaining Dare Bioscience position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 952 Dare Bioscience shares in Q3 2022, an estimated $14K.
  • Victory Capital Management first reported a position in Dare Bioscience in Q3 2019 and held it in 6 quarters.
  • Victory Capital Management's Dare Bioscience position peaked at $21K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.